Mission 01: SARS-CoV-2

We transformed the molecular testing landscape for COVID-19 in India and France.

Mission Objective:
Emergency response to COVID-19 pandemic by deploying highly accessible molecular diagnostic solutions in developed and developing geographies.

Mission Timeline:
December 2020 to April 2022

Mission Status: Successfully Completed

Intervention #1

Worlds Most Affordable
COVID-19 RT-PCR Kit.

We used our expertise to bring about a disruption in the COVID-19 RT-PCR manufacturing industry vertical with the launch of the Detection Expert SARS-CoV-2 rRT-PCR assay in France and India.

In order to facilitate a greater adoption of RT-PCR testing in comparison to 'Rapid' tests, we decided to disrupt the industry by lowering the cost of our COVID-19 RT-PCR diagnostic to less than USD 2.5.

Intervention #2

Asia's Largest Network of Mobile RT-PCR Laboratories.

We further innovated and deployed BSL-2 compliant mobile RT-PCR testing laboratories (daily throughput of 2500 specimens per day per laboratory) for COVID-19 RT-PCR testing with an ambitious target of reducing the cost of patient testing to under USD 5.

The project which was inaugurated by the Hon' Home Minister of India, Shri Amit Shah. Furthermore, the Indian government leveraged this opportunity to scale-up surveillance programs for COVID-19 across different states using molecular diagnostic testing as the front-line screening tool in lieu of 'RAPID' tests. The cost-savings for the Indian government due to our efforts were in the billions of dollars.

Intervention #3

India's Largest Laboratory for COVID RT-PCR Testing.

In our quest to further enhance accessibility of COVID-19 RT-PCR testing services in India, we established a mega-testing laboratory in the national capital with a capacity to process over 100,000 specimens per day.

We further trained and deployed over 1000 medical representatives for specimen collection that enabled direct to patient home testing that delivered results within a time frame of 6 hours.

Intervention #4

Repositioning Supply Chains Back To Europe.

In France, our organisation was able to demonstrate that IVD manufacturing in Europe could be highly cost competitive in comparison to East-Asia.

Our business strategy was successful in capturing a large market share in France, and we demonstrated that supply-chains indeed could be transferred back to Europe while maintaining price competitiveness.